Skip to main content

Modular Team Development Programme

Lines on the earth

About

Teva Kutno SA is the Polish subsidiary of Teva Pharmaceutical Industries Ltd, a top 20 global pharmaceutical company. Impact Polska's team development event included interactive projects which involved the entire team and gave them a chance to put their learning into practice.

Teva Kutno wanted to translate their corporate vision, mission and values into everyday business practice across the organisation.

Following a detailed training needs analysis, Impact Polska designed a comprehensive modular team development event. 196 employees, including managers and representing every department of Teva, came together for the programme.

Immediate benefits noted in the engagement of employees are: improved cross-functional relationships, support of interdepartmental challenges and ownership of personal development.

Business improvement results include a higher level of participation in projects, increased innovation and ideas, increased productivity and greater attention to work quality.

Testimonials
See what our customers say about us
Cate Harris
Group Head of Sustainability & Global Head of Lendlease Foundation
Lendlease
“People always talk about the ‘Magic of Springboard’… I am so pleased to hear that even in a virtual format, during this most unusual of times that it’s still working its magic.”
Stuart Almond
Head of Intelligent Media Services
Sony
“We’ve made changes within the department and division. Not only team structure, but in terms of how we engage with our customers and the market.”
Justyna Jedlińska
Employee Development Manager
Polpharma
“The programme has been tailored the way that we were able to check its effectiveness.
The results of the review confirmed that the number of managers who present strategic and developing styles increased by over 20%. Moreover, the programme had a very positive impact on the inter-departmental / cross-functional cooperation, which is very important in such a large and diverse company as Polpharma."